Diagnostic approach to monkeypox outbreak, a case-control study.

Int J STD AIDS

Department of internal medicine and infectious diseases, 81880CHU Saint Pierre, ULB, Brussels, Belgium.

Published: April 2023

Background: An international outbreak of the monkeypox (MPX) virus is ongoing with a different clinical presentation than previously reported.

Objective: A monocentric retrospective study was designed to investigate clinical predictors of confirmed MPX cases among a group of patients referred for MPX screening. Furthermore, the additional value of performing a real-time polymerase chain reaction (RT-PCR) on multiple anatomical sites was analyzed.

Methods: Between 28/05/2022 and 22/07/2022, the medical records of patients referred for MPX screening were investigated. Patients with positive RT-PCR were defined as cases, while the ones with negative RT-PCR as controls. Multivariable regression analysis was performed to estimate predictors of MPX diagnosis.

Results: Among the 141 included patients, 85 (60%) had at least one positive RT-PCR for MPX. Carrying out RT-PCR only on the swab obtained by skin lesion sampling, 7 patients (7/85: 8%) would have been misdiagnosed. Multivariable regression analysis showed significant differences in the independent variables: "being men who have sex with men (MSM)", "living with HIV", "having multiple sexual partners in the last 3 weeks", and "having skin lesions in the anogenital area" for prediction of MPX diagnosis. These four discriminants were used to create a score to improve diagnosis in patients screened for MPX.

Conclusion: MPX diagnosis was associated with being MSM, living with HIV, having multiple sexual partners, and presenting with anogenital skin lesions. In this study, the derived score had good sensitivity and specificity to predict MPX diagnosis. Finally, performing multi-site swabs for MPX RT-PCR might lower false negative rates.

Download full-text PDF

Source
http://dx.doi.org/10.1177/09564624231152789DOI Listing

Publication Analysis

Top Keywords

mpx diagnosis
12
mpx
10
patients referred
8
referred mpx
8
mpx screening
8
positive rt-pcr
8
multivariable regression
8
regression analysis
8
multiple sexual
8
sexual partners
8

Similar Publications

Objectives: Evaluation of diagnostic accuracy of two point-of-care (POC) molecular diagnostic tests for the detection of monkeypox virus (MPXV): Xpert® Mpox (Cepheid, Inc., USA) and STANDARD™ M10 MPX/OPX (SD Biosensor, Inc., Korea).

View Article and Find Full Text PDF

Background: The Monkeypox virus (MPXV), a member of the Orthopoxvirus genus, is responsible for the zoonotic disease known as MPX. Primarily found in western and central Africa, emerging studies indicate a shift in transmission dynamics. Ongoing MPX outbreaks in the Democratic Republic of Congo (DRC) have escalated into significant public health concerns.

View Article and Find Full Text PDF

Monkeypox (MPX) is a zoonotic viral disease caused by the monkeypox virus (MPXV), which belongs to the Orthopoxvirus genus. The main clinical features of MPX are fever, rash, and lymphadenopathy. It is usually a self-limited disease and can resolve within a few weeks in most cases.

View Article and Find Full Text PDF

The aim of this study was to describe the clinical, histopathological, and immunohistochemical characteristics of MPX and offer meaningful insights into the clinicopathology of MPX. We recruited eight men who had sex with men diagnosed with MPX based on positive results from MPX Virus (MPXV)-specific polymerase chain reaction. Skin biopsies were obtained from four selected lesions, including typical and atypical lesions.

View Article and Find Full Text PDF
Article Synopsis
  • Monkeypox (Mpox) is a disease caused by the monkeypox virus (MPXV), and due to recent outbreaks outside Africa, many may lack immunity specifically for MPXV, though they might have some from past smallpox vaccinations.* -
  • The study involved 16 people who recovered from Mpox and 15 healthy controls, using their blood samples to measure T-cell responses after exposure to MPXV and smallpox vaccine peptides.* -
  • Results showed that those who recovered from Mpox had a significant immune response featuring multiple immune markers, indicating a mixed immune response that could help track immunity from vaccination or infection in the future.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!